Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Women with acne have lower levels of a specific hormone marker than women without acne.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Pregnancy with Cushing's syndrome is rare and risky for both mother and baby, needing early diagnosis and treatment.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.